v3.26.1
SEGMENT INFORMATION (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting [Abstract]        
Clinical trials and other services from R&D-related service providers $ 891 $ 156 $ 5,030 $ 1,893
R&D payroll and related expenses, other than share-based compensation 263 369 1,801 1,231
R&D share-based compensation expense 130 0 0 2,424
G&A payroll and related expenses, other than share-based compensation 241 332 1,527 1,154
G&A share-based compensation expenses 215 21 134 3,438
Professional services 783 525 2,103 1,632
Depreciation 2 4 14 25
Other segment expenses 224 [1] 243 [1] 1,023 [2] 774 [2]
Operating loss 2,749 1,650 11,632 12,571
Interest income (32) (2) (155) (28)
Interest expense 0 11 13 27
Other financing expense, net 16 76 419 3,939
Income taxes [3] [3] 3 10
Net loss 2,733 1,735 11,912 16,519
Segment assets 4,602 8,308 7,215 2,863
Expenditures for segment assets 0 (6) (9) (22)
Segment liabilities $ 4,311 $ 5,722 $ 4,612 $ 6,852
[1] Other segment expenses include mainly general and administrative-related expenses, such as office lease expenses and maintenance and HR expenses.
[2] Other segment expenses include mainly general and administrative-related expenses, such as rent and maintenance expenses, travel and HR expenses.
[3] Represents an amount less than $1